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Abstract: Human milk microorganisms contribute not only to the healthy development of the immune
system in infants, but also in shaping the gut microbiota. We evaluated the effect of the maternal
diet during pregnancy and during the first month of lactation on the human milk microbiota in a
cross-sectional study including 94 healthy lactating women. Microbiota composition was determined
by 16S rDNA profiling and nutrient intake assessed through food questionnaires. Thirteen genera
were present in at least 90% of all samples, with three genera present in all samples: Streptococcus,
Staphylococcus, and Corynebacterium. Cluster analysis indicated two distinct compositions: one marked
by a high abundance of Streptococcus (cluster 1), and other by a high abundance of Staphylococcus
(cluster 2). A global association with milk microbiota diversity was observed for vitamin C intake
during pregnancy (p = 0.029), which was higher for cluster 2 individuals (cluster 2 median = 232 mg/d;
cluster 1 = 175 mg/d; p = 0.02). Positive correlations were found between Bifidobacterium in the milk
and intake of polyunsaturated and linoleic fatty acids during the lactation period (p < 0.01). We show
that maternal diet influences the human milk microbiota, especially during pregnancy, which may
contribute in shaping the gut microbiota.
Keywords: maternal diet; microbiota; breast milk; gut colonization; breastfeeding
1. Introduction
Breast-fed babies develop distinct gut microbiota patterns, more enriched in Bifidobacterium and
Lactobacillus compared to formula-fed babies, which are enriched in species belonging to Clostridia [1].
Such influence is thought to contribute the correct development of the immune system, and improved
health outcomes associated with breastfeeding [2].
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There are very few studies on how or even which microorganisms present in human milk assist on
colonizing the infant gastrointestinal tract, as well as their potential role in the mother and their infant’s
health [3,4]. Species already isolated from human milk include Lactobacillus gasseri, L. rhamnosus,
L. plantarum, L. fermentum, Enterococcus faecium, Bifidobacterium breve, B. adolescentis, B. bifidum, B. longum,
and B. dentium [5–7]. However, studies employing high throughput sequencing have shown that human
milk contains a larger diversity of bacterial species comprising more than 207 bacterial genera [4].
Among these genera, Staphylococcus and Streptococcus are the predominant bacterial genera [4,8], and
it is thought that 12 core genera account for as much as 81% of all bacteria present in human milk
after the first month post-delivery [4]. Nevertheless, there is also a large difference in diversity among
samples, and it remains unclear what such high inter-personal variation may mean for the newborn
microbiome [9].
Pre-gestational body mass index (BMI) [9,10], lactation time [10], mode of delivery [10,11] or
even the geographic location [11] have all been related to the differences in human milk microbiota
composition. In addition, maternal diet [12] and nutrient content in human milk [11,13] have been
recently proposed as factors that may influence its microbiota composition.
How the milk microbiota is modulated is a matter of debate One hypothesis is that the mother’s
diet may help in shaping the human milk microbiota. This is substantiated by previous studies
reporting that specific nutrients from the maternal intake affect the nutrient composition of the human
milk [14,15]. An alternative hypothesis proposes an entero-mammary pathway as a route for bacteria
to reach the human milk, enabling the transfer of bacteria from the maternal gastrointestinal tract to
the mammary gland [13,16]. The diet influences the gut microbiota [17,18] also during the perinatal
period [19], the latter hypothesis suggests that the diet might influence the human milk microbiota
diversity via changes in the maternal gut microbiota diversity. This might explain the origin of bacteria
in milk that are not found on the maternal skin or in the infant’s mouth, which are described as
potential bacterial sources shaping the human milk microbiota [16,20,21].
Since vertical transfer of bacteria via breastfeeding has been suggested as an important contributor
to the initial establishment of the microbiota in the developing infant gut [4], it is important to
understand factors that might influence the composition of the human milk microbiota, especially the
role of maternal diet for which limited information is available. To our knowledge, the relation between
the maternal diet during pregnancy and the milk microbiota has not yet been explored. Here we
evaluated the effect of the maternal diet during pregnancy and during the first month of the lactation
period on the human milk microbiota profile.
2. Materials and Methods
2.1. Subjects and Study Design
A cross-sectional investigation was carried out including healthy lactating women volunteers
of 18 to 37 years old with uncomplicated pregnancy. Women who had vaginal deliveries at the
University Hospital, University of São Paulo, São Paulo city, between September 2014 and June 2016
were assessed for eligibility for inclusion into the study. Inclusion criteria were having babies born
between week 37 and 42 of pregnancy with weight between the 10th and 90th percentiles (adequate
weight for gestational age), according to the United States reference curve for fetal growth [22],
having normal bowel frequency (minimum once every 2 days, maximum 3 times per day), and
breastfeeding. The volunteers were screened through medical records and from oral information.
Exclusion criteria were current chronic gastrointestinal disease, genetic disease, cardiac disease, kidney
disease, hypertension, diabetes mellitus, immunodeficiency diseases, eclampsia, gestational diabetes,
mastitis during lactation period. Further exclusion criteria were use of proton pump inhibitors,
H2 receptor antagonists, antidepressants, narcotics, anticholinergic medications, laxatives, regular
consumption of commercially available prebiotic- or probiotic-supplemented products, anti-diarrhea
and antibiotics medications within 30 days prior to collection of the milk samples.
Microorganisms 2019, 7, 502 3 of 18
The project was approved by the Research Ethics Committee of the School of Pharmaceutical
Sciences, University of São Paulo, São Paulo, Brazil on 27th May 2014 and by the Research Ethics
Committee of the University Hospital, University of São Paulo, São Paulo, Brazil on 7th July 2014
-CAAE: 27247614.6.0000.0067. The selected women were invited to participate in the study and enrolled
after signing the Written Informed Consent Form.
After the screening, two meetings were scheduled at day 7 (±3) and day 30 (±4) after delivery
(Figure S1). During the first meeting, a structured questionnaire was conducted to collect data on age,
family income, number of children, use of supplements/medicines during pregnancy/lactation, bowel
frequency, alcohol consumption, smoking, pre-gestational and perinatal anthropometric data (weight
and height) and information about the newborn. In addition, the first 24 h food recall (24 h-day 7) for
the maternal diet record was performed.
On day 30 (±4) after delivery, a second meeting was held including collection of human milk at
the University Hospital. In the first meeting the volunteers had a medical appointment in addition
to the research meeting. Due to the longer available time of the volunteers, we chose to collect milk
on day 30. To reduce the intra-personal variability in food consumption assessment, an additional
24 HR (24 h-day 30) was performed. Additionally, a quantitative food frequency questionnaire (QFFQ)
relative to the pregnancy period was performed.
2.2. Maternal Diet Records
The maternal diet records during pregnancy were estimated by QFFQ, developed and validated
for pregnant women in Brazil to encompass the entire period of pregnancy [23]. The QFFQ includes
85 items of usual foods and recipes for this population, the consumption frequency (daily, weekly,
monthly or during the gestational period), the number of times the participant consumes a particular
food item, the median portion (in household measures and in g/mL), and the size of the portion of each
participant. The 24 h comprised information about the food intake during the last 24 h prior to the
interview, data on foods and beverages currently consumed, including preparation, and information
on weight and portion size in grams, milliliters or home measures. The 24 h were performed through
the Multiple-Pass Method, in which the respondent is guided through five steps (quick list, forgotten
foods list, time and occasion, detail and review, final probe) in a standardized process, which helps to
maintain the individual interested and engaged in the interview, and helps them to remember all the
items consumed [24], and when necessary, changes were made to adequate the Brazilian food reality.
The food surveys were conducted by trained nutritionists.
It is noteworthy that differences in the methods used in the present study to investigate the usual
intake during pregnancy (QFFQ) and during lactation (24 h) was due to the study design, which was
planned to start after delivery. This was due to the inclusion criteria, which included only women who
had vaginal delivery in order to avoid adding more variables in the study. Therefore, since we could
not predict the mode of delivery of the volunteer, it was unfeasible to collect 24 h from the period
of pregnancy.
The Nutrition Data System for Research (NDSR, version 2014, Center for Nutritional Coordination,
University of Minnesota, Minneapolis, MN, USA) was used to convert the information from the
food intake report from the QFFQ and the two 24 h to nutrients, for analysis of nutrients consumed
during the pregnancy and lactation periods studied. Since this software uses the American food
composition database developed by the United States Department of Agriculture (USDA), the adequacy
of nutritional values was checked using the Brazilian Table of Food Composition [25]. In addition,
folate and iron values were adjusted considering the mandatory fortification of prevailing wheat and
corn flours in Brazil since 2004. In case of nutritional supplement used by the volunteers, these were
added to the consumption data.
The nutrient data from 24 h were processed in the Multiple Source Method program, in order
to estimate the usual dietary intake of the volunteer during the lactation period [26]. Afterwards,
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the nutrients intake from QFFQ and 24 h data was normalized using the residual method to standardize
for energy intake [27].
We reinforce that, as a cross-sectional study, no food or supplement were supplied by the
researchers to the volunteers during the study and that their diets were consumed ad libitum.
2.3. Human Milk Samples Collection
Human milk samples were taken from volunteers at 30 (±4) days after delivery, at the University
Hospital of the University of São Paulo, according to Martín et al. [7] and Jost et al. [28]. The women
were informed to clean their nipple and surrounding area with chlorhexidine 1% to reduce the presence
of skin bacteria. Next, the first drops (approximately 200 µL) were discarded and the milk samples
were collected in a sterile tube by manual pressure using sterile gloves. All the samples were kept on
ice for up to 4 h; the samples were then aliquoted and stored at −80 ◦C for later DNA extraction.
2.4. DNA Extraction
Total DNA was extracted with the QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany), according
to the manufacturer’s protocol for Gram-positive bacteria, with slight adaptations. Briefly, 1.5 mL of
human milk sample was centrifuged at 15,700× g for 15 min to pellet prokaryotic cells. The supernatant
was discarded, and the pellet washed in 1000 µL of Tris EDTA (10 mM Tris-HCl [pH 7.5], 1 mM EDTA
[pH 7.6]) buffer. The suspension was centrifuged at 15,700× g for 15 min. The samples were lysed
in 200 µL of TELS (20 mg/mL lysozyme:1 M Tris-HCl [pH 7.5], 0.5 M EDTA [pH 8.0], 20% sucrose)
buffer. Next, it was incubated for 60 min at 37 ◦C. The next steps followed the manufacturer’s
instructions. DNA quality and concentrations were determined using a Nanodrop ND-1000 (Thermo
Fisher Scientific, Waltham, MA, USA).
Additionally, to control for bacterial DNA contamination that may derive from reagents in the DNA
extraction kit, we extracted DNA from a tube only containing the reagents from the DNA extraction kit
(“Blank”), and moreover made a non-template PCR control (NTC) alongside the milk samples.
2.5. Amplicon Sequencing
The PCR-based library formation was performed by a nested PCR. The primers are listed in
the Table 1.
Table 1. Primers used for the PCR-based library formation.
Primer Sequence Reference
PCR 1st round
341F CCTAYGGGRBGCASCAG Yu et al. [29]
806R GGACTACHVGGGTWTCTAAT
PCR 2nd round
515F AATGATACGGCGACCACCGAGATCTACAC-NNNNNNNN-GTGTGCCAGCMGCCGCGGTAA* Caporaso et al. [30]
806R
CAAGCAGAAGACGGCATACGAGAT-
NNNNNNNNNNNNAGTCAGTCAGCCGGACTAC
HVGGGTWTCTAAT*
* These primers are targeting the 16S rRNA gene’s variable region (V4), where “N” denotes index sequence
for multiplexing.
The PCR reactions were carried out in a 25 µL mixture (final volume), containing 500 nM (for
the first round) or 200 nM (for the second round) of each primer pair, 0.2 mM dNTPs (Thermo Fisher
Scientific, Waltham, MA, USA), 0.5 units Phusion high fidelity DNA polymerase (Thermo Fisher
Scientific, Waltham, MA, USA), 1 × Phusion Green HF buffer (Thermo Fisher Scientific), and 10 µL of
sample DNA (for the first round) or 2 µL of PCR product from the first amplification (for the second
round). Cycling conditions were: 98 ◦C for 30 s, followed by 40 cycles for the first or 15 cycles for second
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round of amplification, consisting of 98 ◦C for 5 s, 56 ◦C for 20 s, and 72 ◦C for 20 s. Negative controls
with buffer from the DNA extraction kit controls were included in the PCR runs.
The PCR products were purified using Agencourt AMPure XP beads (Beckman Coulter, Danvers,
MA, USA). The amplicon concentration was quantified using the Quant-iT PicoGreen dsDNA assay
kit (Thermo Fisher Scientific, Waltham, MA, USA). Subsequently, samples were pooled using 3.6 ng
of each. The pooled samples were loaded onto the Illumina MiSeq clamshell style cartridge kit v2 at
500 cycles, for paired-end 250 sequencing at the final concentration of 4 pM on an Illumina MiSeq
(Illumina®, San Diego, CA, USA).
2.6. 16SrRNA Gene Sequence Processing
For 16S rRNA gene data analysis, generated sequences were analyzed using Quantitative Insights
Into Microbial Ecology (QIIME) v1.9.1 with default settings. Chimera checking was performed
using UCHIME69 and de novo Operational Taxonomic Units (OTU)-picking was performed using
UCLUST70 with 97% sequence similarity. Representative sequences were assigned taxonomy against
the Greengenes database v13_871 using the RDP-classifier [31].
Subsequent analyses were performed with the R version 3.4.3 using the metagenomeSeq [32],
phyloSeq [33], vegan [34], and ggplot2 [35] packages. Data were filtered for low abundance of OTUs
by removal of OTUs present in fewer than 3 of all the samples and with a relative abundance higher
than 0.5% across all OTUs.
After quality filtering an average of 33,217 high-quality 16S rRNA gene sequences per sample
remained. Reads were classified into 334 OTUs covering a median of 95 percent of total number of
species across samples (min-max: 92–98).
The global microbiota composition in the milk samples was distinct from the analytical controls
(PERMANOVA, controls vs. milk samples, p = 0.001) and we found no significant correlations between
abundances at the Genus level in the analytical controls versus milk samples (Figure S2). Thus,
we considered that any eventual contamination included during sample preparation was negligible to
the remaining analysis.
2.7. Statistical Analysis
Statistical analysis was performed on data filtered based on effective sample sizes, where samples
were not included if they had fewer than 10,000 or more than 100,000 OTUs.
All statistical analyses were performed using R (R version 3.4.3, Vienna, Austria). For differences
in the human milk microbiota composition, PERMANOVA was performed using the Adonis function
in vegan [34] with weighted UniFrac distance. For each variable, 999 permutations were made.
Associations between nutrient intake and microbial taxa were conducted using Spearman rank
correlation tests.
For the clustering analysis, samples were clustered based on relative genus abundances, and using
weighted UniFrac distance via partitioning around medoid (PAM) clustering algorithm in the R package
“cluster” [36]. Optimal number of clusters was estimated using the prediction strength (PS) [37].
Alpha-diversity analyses were performed after applying rarefactions (10,000 sequences/sample) to
standardize sequence counts (vegan package). After checking for normality, t-test or Wilcoxon signed
ranks test was used for parametric or non-parametric data to compare clusters and variables.
A false discovery rate p value ≤ 0.01 was considered as significant for Spearman’s correlation tests.
A standard p value < 0.05 was considered as significant for all other analyses.
2.8. Data Deposition and Materials Sharing
Sequence data have been deposited in the National Center for Biotechnology Information (NCBI)
under the project number PRJNA479106 (https://www.ncbi.nlm.nih.gov/Traces/study/?acc=SRP151896)
and are available under SRA accession SRP151896.
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3. Results
Two hundred forty-three lactating women were assessed for eligibility for inclusion in the study.
Of this group, 12 refused to participate, 10 did not meet the inclusion criteria, 119 did not attend all the
meetings, and 8 volunteers were excluded during analysis as their samples did not yield sufficient
sequencing depth. Thus, milk collected at 1-month post-partum from 94 volunteers was included in
the analysis. The clinical and demographic characteristics of these volunteers are shown in Table 2.
Table 2. Clinical and demographic characteristics of the volunteers included in the analysis (n = 94).
Variables Values
Maternal age (years) 27 (22.3–29)
Race
Black/Brown 41 (44)
White 53 (56)
Family income estimated (USD/month) * 462.5 (462.5–770.39)
Number of children
1 32 (34)
2 or more 62 (66)
Duration of pregnancy (weeks) 39 (38–40)
Maternal antibiotic treatment
Number with treatment during pregnancy 26 (28)
Number with treatment during delivery 40 (42)
Alcohol drinking during pregnancy 5 (5.3)
Smoking during pregnancy 9 (9.5)
BMI before pregnancy (kg/m2) 23.0 (21.1–24.6)
Maternal weight gain over pregnancy (kg) 11.4 (8.7–14.0)
Anesthesia
No anesthesia 63 (67.1)
Pudendal block 3 (3.1)
Epidural 5 (5.3)
Spinal 23 (24.5)
BMI at day 30 after delivery (kg/m2) 23.8 (22.1–26.7)
Infant diet at day 30 after delivery
Exclusively breast milk 79 (83)
Breast milk + formula ** 16 (17)
Infant weight gain over 30 days after birth (g) 1160 (890–1470)
Data presented as median (interquartile range) or n (%). BMI: body mass index (kg/m2). * Family income estimated
by Brazilian Economic Classification Criteria (Brazilian Criteria) 2016. ** Frequency of offering formula≤ 3 times/day.
3.1. The Milk Microbiota of Brazilian Mothers is Dominated by Streptococcus, Staphylococcus,
and Corynebacterium
The characterization of the microbiota in the milk of 94 volunteers showed that Firmicutes was the
most abundant phylum (a mean average of 70%), followed by Actinobacteria (14.5%), Proteobacteria (14%),
and Bacteroidetes (1%) (Figure S3). A total of 85 genera were identified across human milk samples.
However, we found a core consisting of three genera present in all samples: Streptococcus, Staphylococcus,
and Corynebacterium (relative mean abundances of 42%, 22%, and 7%, respectively), and ten genera
present in at least 90% of the samples: Rothia (relative mean abundance of 0.67%), Veillonella (0.41%),
Rubrobacter (0.38%), Pseudomonas (0.32%), Halomonas (0.28%), Trabulsiella (0.19%), Chelonobacter (0.14%),
Acinetobacter (0.11%), Actinomyces (0.08%) and Lactobacillus (0.06%). Bifidobacterium, an important genus
reported to influence infant health, was present in 78% of the samples and in relative mean abundances
of 1% (Figure 1) and family Bifidobacteriaceae was detected in 84% of all samples.
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3.2. Maternal Diet during Pregnancy Modulates Milk Microbiota Composition while the Diet during Lactation
Results in Minor Changes in Taxa Abundance
We evaluated the effect of the maternal diet by one QFFQ relative to the pregnancy period and two
24 h to estimate intake of nutrients during the first month of lactation. To identify associations between
nutrients and human milk bacteria community, PERMANOVA tests were performed using the weighted
UniFrac distance for each nutrient, with each nutrient as a dependent variable. Significant differences
in microbiota composition were found for the intake levels of vitamin C during pregnancy (p = 0.029)
(Table S1). No significant differences were found for nutrients intake from the lactation period.
The bacteria composition of human milk at 1-month post-partum was found not to be significantly
affected by maternal ethnicity (race), age, socioeconomic level, number of children, duration of
pregnancy, antibiotic use during pregnancy/delivery, Body Mass Index (BMI) before pregnancy, weight
gain during pregnancy, anesthesia at delivery, BMI at day 30 after delivery, sporadic offering of infant
formula, or infant weight gain during the first month after birth (Table S1).
Spearman’s correlations identified further associations between nutrients and bacterial genera
(Figures S4 and S5). Correlation between nutrients and bacterial genera differed in relation to
maternal diet estimated during pregnancy and lactation period. There were 17 significant correlations
detected between diet assessed during pregnancy and the milk genera detected, while diet during
the lactation period showed 41 significant correlations with the milk bacterial genera detected,
although most of the correlations during the lactation period were found for genera present at low
relative abundance in the samples. (Figures S4 and S5). Particularly, the intake of vitamin C during
pregnancy was positively correlated with the presence of Staphylococcus genus (rho = 0.25, p = 0.01).
For the lactation period, positive correlations were found between Bifidobacterium and intake of
polyunsaturated fatty acids (PUFAs) (rho/coefficient = 0.29, p = 0.005) and linoleic acid (rho/coefficient
= 0.27, p = 0.007). In addition, negative correlations were found between intake of sugars and
Pseudomonas (rho/coefficient = −0.27, p = 0.0085) and positive correlations were found between intake
of vitamin B9 and Pseudomonas (rho/coefficient = 0.29, p = 0.0053). The intake of complex B vitamins,
particularly B1 (rho/coefficient = −0.38, p = 0.0002), B2 (rho/coefficient = −0.27, p = 0.0084), and B9
(rho/coefficient = −0.43, p = 0.00001) were negatively correlated with Enterococcus.
Next, we grouped the samples in clusters based on microbiota profile similarities. The highest
prediction strength using weighted UniFrac was obtained for two clusters (prediction strength = 0.78
for 2 clusters, Figure S6). Principal Coordinate Analysis (PCoA) indicated that these two clusters were
driven by Streptococcus (cluster 1) and Staphylococcus (cluster 2) (Figure 2).
Other differences between the clusters were found for the genera Corynebacterium [1.8% (cluster
1) vs. 4.3% (cluster 2); p = 0.007], Pseudomonas [0.2% (cluster 1) vs. 0.7% (cluster 2); p = 0.003], Rothia
[2.6% (cluster 1) vs. 0.3% (cluster 2); p = 0.00001] and Trabulsiella [0.1% (cluster 1) vs. 0.3% (cluster 2);
p = 0.006]. Bifidobacterium was detected in slightly higher amounts in cluster 2, but this difference was
not statistically significant.
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No differences were found between the clusters in term of genus richness (Chao1 index),
and alpha-diversity (Shannon index) (Figure S7). Clusters did not differ with respect to maternal
ethnicity, age, socioeconomic level, number of children, duration of pregnancy, antibiotic use during
pregnancy/delivery, BMI before pregnancy, weight gain over pregnancy, anesthesia at delivery, BMI at
day 30 after delivery, sporadic offering of infant formula or infant weight gain over 30 days after birth
(Table S2).
We found differences in vitamin C intake by the mothers during pregnancy based on the milk
microbiome clusters (median in cluster 1 = 175 mg/d, cluster 2 = 232 mg/d, p = 0.0249; Figure 3a).
The vitamin C intake was higher in cluster 2, driven by the Staphylococcus genus. We also found trends
towards higher levels of intake of pectin (Figure 3b, p = 0.053) and lycopene (Figure 3c, p = 0.058)
during pregnancy in cluster 2, even though this trend was not statistically significant. No statistical
differences were found for nutrient intake during the first month of lactation based on milk microbiome
clusters (Table S2).
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4. Discussion
The importance of human milk on the infant’s health is well documented. Over the last years,
studies have focused on the potential role of human milk in the development of the immune system
during infancy and childhood [38], as well as on modulating the infant gut microbiota [39].
Our results revealed that 4 phyla-Firmicutes, Actinobacteria, Proteobacteria, and Bacteroidetes are
dominating in the human milk microbiota on day 30 after delivery. In line with previous studies
Firmicutes and Proteobacteria were the most abundant phyla [4,40]. At the genus level, Streptococcus
(Firmicutes) and Staphylococcus (Firmicutes) were identified as the most abundant genera, followed
by Corynebacterium (Actinobacteria). We found more than 80 genera showing that the human milk
microbiota hosts a diverse set of bacteria.
Several studies have identified Staphylococcus and Streptococcus as the most abundant genera in
human milk [9,41]. Since these genera are typical inhabitants of the skin and oral cavity, our findings are
consistent with the hypothesis of a retrograde flux of bacteria present on the mother’s skin/infant’s oral
cavity to the human milk, enabling these bacteria to contribute to the composition of the human milk
microbiota [42]. Previous studies have reported a human milk core microbiome consisting of several
genera [4,9]. However, we have detected five genera (Staphylococcus, Streptococcus, Corynebacterium,
Pseudomonas and Lactobacillus) previously reported and additionally seven genera present in at least
90% of the studied individuals.
Since Bifidobacterium and Lactobacillus are highly present in the gut microbiota of breast-fed infants,
we expected to find these genera in relative high abundance also in the milk. Surprisingly, the average
relative abundances ranged from just 0.1 to 1% for Bifidobacterium and from 0.1 to 0.3% for Lactobacillus.
This is less than reported in previous studies by Urbaniak et al. [40] who reported around 3% of
Lactobacillus, and Murphy et al. [4] who reported around 2% of Bifidobacterium and Lactobacillus in the
first weeks after delivery. This differences could indicate a broader human milk core microbiota, of
point at inherent differences in the human milk microbiota from Brazilian women, as well as differences
in methodological factors, including DNA extraction procedures, PCR bias, use of different primer sets
assessing different 16S rRNA gene regions, as well as depth of sequencing of the study [28].
The microbiota from all samples was classified into two clusters driven by Streptococcus and
Staphylococcus. This is in line with previous studies of human milk samples, although the two genera
were reported with higher relative abundance [9,11,40]. Indeed, a recently published systematic review
of the human milk microbiota identified the predominance of Streptococcus and Staphylococcus in
12 analyzed studies, suggesting that these genera may be universally predominant in human milk,
regardless of differences in geographic location or analytic methods [8].
Interestingly, Li et al. [43] reported 3 clusters based on family profiles of human milk microbiota
in samples collected from Taiwan and six regions of mainland China. The clusters were driven by the
Streptococcaceae, Staphylococcaceae or Pseudomonadaceae families showing that taxonomic differences in
clusters do occur.
The impact of Staphylococcus and Streptococcus on the infant’s health is not completely clear, but it
is known that these genera are present in the infant’s gut, especially during the first weeks [1,44,45].
Studies suggest that Staphylococcus and Streptococcus, as well as other facultative aerobic species are the
initial gut colonizers. These species contribute to the consumption of oxygen from the infant’s gut,
providing a suitable environment for the colonization of strict anaerobic species, such as Bifidobacterium,
Bacteroides, and Clostridium [46].
In our study, we did not find any effect on the two bacterial clusters dominated by Streptococcus and
Staphylococcus by maternal socioeconomic/clinical information or nutrient intake during the lactation
period. However, weak positive correlations were found between the intake of polyunsaturated/linoleic
fatty acids during the lactation period and Bifidobacterium in the milk, genus considered of importance
for the infant’s health [47,48]. In fact, previous studies have reported a relation between the PUFA intake
and milk composition [15,49]. Recently, the new consensus statement on the definition and scope of
prebiotics includes PUFA as a prebiotics [50]. According to Gibson et al. [50] the mechanisms involved
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in the prebiotic property of PUFA are related to the conversion into the conjugated linoleic acid (CLA)
and conjugated linolenic acid (CLnA). In line with the positive correlations between PUFA/linoleic acid
and Bifidobacterium found in this study, the conversion of PUFA into CLAs is reported to be followed
by growth of Bifidobacterium [51].
During the lactation period, we also found negative correlations between intake of thiamin,
riboflavin, and folate and the Enterococcus genus. The Enterococcus genus has been found in human milk
samples in previous studies [4,11], as well as in the infant gut [1]. We predicted positive correlation
between these vitamins and Enterococcus, since most Enterococci require complex B vitamins in their
metabolism for maximal growth [52]. However, this was not the case. The fact that vitamins usually
are bound to other compounds, predominantly proteins, might suggest that maternal factors regulating
protein secretion are more likely to affect milk levels of these vitamins than the fluctuating maternal
intake [52].
Although we did not find any statistically significant differences among maternal diet in the
lactation period and the clusters, we found significant differences between the level of vitamin C
intake during pregnancy and the clusters, with higher levels of vitamin C intake in cluster 2, driven by
the Staphylococcus genus. This finding is in accordance with the results obtained by the Spearman’s
correlation test, indicating a positive correlation between vitamin C intake during pregnancy and the
Staphylococcus genus.
In contrast to our findings, vitamin C has been reported to inhibit the growth of Staphylococcus [53].
However, most of the studies investigated the impact of high concentrations of this vitamin (more than
1 g/L), which is above the physiologic concentrations found in human milk samples (ca. 0.04 g/L) [53,54].
On the other hand, other studies performed with citrus fruit juice, which are rich in vitamin C, showed
no negative effect on abundance of Staphylococcus [55,56].
Although the role of vitamin C in Staphylococcus metabolism remains unclear, both have been
linked to the development of the immune system. According to Hoppu et al. [57] higher vitamin C
levels in breast milk was associated with reduced risk of atopy in high-risk infants. At the same time,
non-allergic children were shown to have higher counts of Staphylococcus in feces, when compared to
allergic counterparts [58,59]. In this context, Salminen et al. [60] suggested that Staphylococcus aureus,
traditionally considered as harmful, but frequently isolated from infant feces, may aid in educating the
coevolving immune system. Thus, the link between vitamin C and Staphylococcus abundance warrant
further investigation.
We also observed a tendency towards higher maternal intakes of pectin and lycopene during
pregnancy in cluster 2. It is noteworthy to mention that vitamin C, pectin, and lycopene are compounds
typically found together in citrus fruits [61]. In this context, higher maternal consumption of citrus
fruit, as well as vegetables and β-carotene during pregnancy were protective against the development
of eczema in the offspring, in line with the positive effects of vitamin C and Staphylococcus on the
immune system [62].
Curiously, fruits and fruit juices have been reported as craved foods in pregnancy by several
studies [63]. The fluctuations of hormones and the instinct to protect the embryo from toxic substances
and pathogens have been hypothesized to be the reason for food cravings, and/or aversions [63,64].
We speculate that this behavior commonly found in pregnant women could be, not only related
to the physiology of pregnancy, but also a contributor for the bacterial community structure in the
human milk.
In a previous study, Wu et al. [18] demonstrated the association between the long-term dietary
patterns and gut enterotypes; particularly protein and animal fat were associated with Bacteroides and
carbohydrates with the Prevotella enterotype. Our results again highlight the effects of long-term over
short-term dietary habits, herein represented by the maternal intake during pregnancy.
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5. Study Limitation and Future Directions
It is a limitation of this study that the QFFQ for pregnancy was collected once, at day 30
post-partum. Follow-up studies considering several points of food records collection, as well as
daily longitudinal sampling or more points of sampling over the lactation period would allow us to
test directly for associations between dietary components and microbiome composition within each
participant and the identification of microbiota patterns over time.
In addition, the correlations between maternal nutrients intake and milk microbiota were done
by tests with unadjusted p-values, and as such this should be taken as an observational study.
Interventional trials would be interesting to test the impact of certain foods or nutrients, (e.g., vitamin
C, polyunsaturated fatty acids) on the milk microbiota composition, to validate our findings.
The lack of reports on the role of nutrients in the metabolism of different bacteria in human milk,
and the limited knowledge regarding the availability of macro and micronutrients in the human milk
for the bacterial use complicate data interpretation. Thus, in vitro studies with bacteria isolated from
human milk inoculated in human milk/culture media containing different concentrations of nutrients
are warranted.
6. Conclusions
In conclusion, our results demonstrate that the maternal diet influences the human milk microbiota,
and that the effects of the maternal diet seem to be different for diet during pregnancy and during the
lactation period. The diet during pregnancy has a stronger impact on the bacterial community structure
compared to the diet during the first month of lactation, where specific nutrients in contrast showed to
differentially affect abundances of specific bacterial genera. For dietary patterns during pregnancy,
intake of vitamin C was clearly associated with the composition of the human milk microbiota.
Minor changes in genus abundances were found to correlate with the maternal short-term food intake,
represented by the lactation period. Specifically, PUFA/linoleic fatty acid correlated positively with
the relative abundance of the genera Bifidobacterium in human milk, which may play a role in the
composition of the developing infant gut microbiota.
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each sample; white-filled small circles denote outliers. Mann-Whitney test was performed to compare the values
between the clusters.
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